Tags: Drug.

Bremelanotide /ˌbrɛmɨˈlænətaɪd/ (formerly PT-141) is a compound under drug development by Palatin Technologies as a treatment for female sexual dysfunction hemorrhagic shock and reperfusion injury.

Bremelanotide_chemical_structure.png
ATC prefix
none
CAS number
189691-06-3
FDA UNII code
6Y24O4F92S
IUPAC name
(3S6S9R12S15S23S)-15-[(N-acetyl-(L)-norleucyl)amino]-9-benzyl-6-3-[(diaminomethylidene)amino]propyl-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-258111417-hexaoxo-147101318-hexaa zacyclotricosane-23-carboxylic acid
PubChem
9941379

Loading...

This page contains content from the copyrighted Wikipedia article "Bremelanotide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.